Related Experiment Video
Updated: May 13, 2026
06:35
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Polyneuropathy and myopathy in the elderly.
R E Dalton1, R S Tripathi, E E Abel
1Department of Anesthesiology, The Ohio State University Medical Center, Columbus, Ohio, USA.
HSR Proceedings in Intensive Care & Cardiovascular Anesthesia
|February 27, 2013
Summary
Critical illness polyneuropathy and myopathy (CIPNM) affects intensive care unit patients, predicting mortality. Awareness is crucial as aging populations increase its incidence, especially in the perioperative period.
Area of Science:
- Critical care medicine
- Neurology
- Geriatrics
Background:
- Critical illness polyneuropathy and myopathy (CIPNM) is a complication of intensive care unit (ICU) therapies.
- CIPNM is an independent predictor of mortality in critically ill patients.
- The incidence of CIPNM is expected to rise due to an aging global population.
Purpose of the Study:
- To provide a concise overview of CIPNM.
- To discuss the diagnosis, associations, and potential interventions for CIPNM.
- To emphasize the importance of vigilance among healthcare professionals.
Main Methods:
- Literature review and synthesis of current knowledge on CIPNM.
- Analysis of diagnostic criteria and challenges.
- Examination of risk factors and therapeutic strategies.
Main Results:
- CIPNM is linked to prolonged ICU stays and mechanical ventilation.
- Early diagnosis and management can potentially improve outcomes.
- Multidisciplinary collaboration is essential for optimal patient care.
Conclusions:
- CIPNM poses a significant and growing challenge in critical care.
- Physicians across various specialties must be aware of CIPNM's rising incidence.
- Further research into effective interventions is warranted to mitigate the impact of CIPNM.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...